89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,664,907 | +21.7% | 1,208,867 | +49.4% | 0.00% | 0.0% |
| Q2 2023 | $15,334,264 | -22.2% | 809,196 | -37.5% | 0.00% | -25.0% |
| Q1 2023 | $19,719,819 | +218.9% | 1,294,801 | +166.6% | 0.00% | +100.0% |
| Q4 2022 | $6,183,598 | +401.1% | 485,750 | +127.9% | 0.00% | – |
| Q3 2022 | $1,234,000 | +589.4% | 213,100 | +283.8% | 0.00% | – |
| Q2 2022 | $179,000 | +159.4% | 55,519 | +202.3% | 0.00% | – |
| Q1 2022 | $69,000 | -77.6% | 18,366 | -22.2% | 0.00% | – |
| Q4 2021 | $308,000 | +6.2% | 23,600 | +59.5% | 0.00% | – |
| Q3 2021 | $290,000 | -47.7% | 14,800 | -50.0% | 0.00% | – |
| Q2 2021 | $554,000 | -51.1% | 29,600 | -38.2% | 0.00% | – |
| Q1 2021 | $1,133,000 | +41.6% | 47,868 | +45.9% | 0.00% | – |
| Q4 2020 | $800,000 | – | 32,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |